Equity Overview
Price & Market Data
Price: $4.73
Daily Change: -$0.14 / 2.96%
Daily Range: $4.69 - $4.87
Market Cap: $203,515,166
Daily Volume: 23,954
Performance Metrics
1 Week: -2.07%
1 Month: -16.09%
3 Months: -14.00%
6 Months: -37.68%
1 Year: -42.03%
YTD: -43.15%
Company Details
Employees: 183
Sector: Health technology
Industry: Medical specialties
Country:
Details
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.